activesellsec_filings

OKTA 10-Q report for 2025-10-31

This play aggregates Okta, Inc.’s Form 10-Q for the quarter ended October 31, 2025. The filing includes condensed consolidated financial statements, management’s discussion and analysis, risk factors, and other standard 10‑Q disclosures. Use this document to confirm reported quarterly results, balance-sheet position, and stated risk factors; it does not itself provide forward guidance beyond management’s forward‑looking statements in the filing.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

OKTA — Okta, Inc. (Class A common stock: OKTA) — Nasdaq-listed. As of November 28, 2025, 169,459,250 Class A and 7,770,971 Class B shares outstanding (filing-disclosed counts).

OKTAOkta, Inc.sellopen

Okta, Inc.

Confidence: 60 / 100Start: $81.87Latest: $78.42Return: 4.21%

This item is Okta, Inc.’s Quarterly Report on Form 10‑Q for the period ended October 31, 2025. The filing provides unaudited condensed consolidated financial statements (balance sheet, statements of operations, comprehensive income, stockholders’ equity and cash flows), MD&A, risk factors, and other standard 10‑Q disclosures. Key reported metrics from the filing: total assets $9,229m; total stockholders’ equity $6,893m; cash and cash equivalents $645m; short-term investments $1,818m; total revenue for the three months ended October 31, 2025 of $742m (subscription $724m); net income for the three months ended October 31, 2025 of $43m and for the nine months ended October 31, 2025 of $172m. The filing also discloses outstanding shares and convertible senior notes details. This is primary-source, company-filed disclosure suitable for confirming reported results and balance-sheet items; it contains management’s forward-looking statements and risk-factor disclosures but does not replace deeper due diligence or forward-looking model work.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: Okta, Inc. Quarterly Report on Form 10‑Q for the period ended October 31, 2025 (cover page, table of contents, condensed consolidated financial statements and notes). The filing includes balance sheets, statements of operations, comprehensive income, stockholders’ equity and cash flows (unaudited).

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is only the cover/header portion of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

The provided text is only the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided excerpt is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Single authoring source (company filing). Financial tables and narrative originate from Okta’s Form 10‑Q; no external analyst commentary included.

Unlock full thesis monitoring

Review the full 10‑Q for detailed notes, MD&A, risk factors and exhibits before making trading decisions. For model updates, reconcile these reported results with your forecasts and check for related SEC amendments or subsequent company disclosures.